Expression Table for this CRE
| CNhs14376 | mesothelioma cell line:Mero-14 | 7.5 |
| CNhs14083 | putamen, newborn, donor10223 | 4.8 |
| CNhs12955 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4) | 4.3 |
| CNhs12366 | mesenchymal precursor cell - bone marrow, donor1 | 4.0 |
| CNhs12318 | substantia nigra, adult, donor10252 | 3.9 |
| CNhs14218 | hIPS +CCl2, biol_rep2 | 3.8 |
| CNhs13215 | CD4+CD25-CD45RA- memory conventional T cells expanded, donor1 | 3.7 |
| CNhs14613 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3 | 3.6 |
| CNhs13435 | achilles tendon, donor2 | 2.8 |
| CNhs12059 | Fibroblast - Dermal, donor6 | 2.7 |
| CNhs14186 | Smooth muscle cells - airway, asthmatic, donor3 | 2.7 |
| CNhs14436 | COBL-a rinderpest(-C) infection, 06hr, biol_rep2 | 2.7 |
| CNhs13049 | acute myeloid leukemia (FAB M7) cell line:M-MOK | 2.6 |
| CNhs12054 | Bronchial Epithelial Cell, donor4 | 2.6 |
| CNhs13338 | mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1 | 2.6 |
| CNhs12060 | Skeletal Muscle Cells, donor6 | 2.6 |
| CNhs14542 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2 | 2.6 |
| CNhs13490 | CD14+ monocytes - treated with IFN + N-hexane, donor3 | 2.5 |
| CNhs12104 | Mesenchymal Stem Cells - amniotic membrane, donor2 | 2.5 |
| CNhs12048 | Smooth Muscle Cells - Subclavian Artery, donor3 | 2.5 |
| CNhs12005 | Astrocyte - cerebral cortex, donor3 | 2.5 |
| CNhs13839 | iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 2.4 |
| CNhs14080 | locus coeruleus, newborn, donor10223 | 2.3 |
| CNhs13660 | HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1 | 2.3 |
| CNhs14138 | bronchioalveolar carcinoma cell line:NCI-H650 | 2.3 |
| CNhs12020 | Chondrocyte - de diff, donor3 | 2.3 |
| CNhi10525_AGT | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep1 | 2.3 |
| CNhs14437 | COBL-a rinderpest(-C) infection, 06hr, biol_rep3 | 2.2 |
| CNhi10789_ATG | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep3 | 2.2 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 2.2 |
| CNhs12046 | Smooth Muscle Cells - Internal Thoracic Artery, donor3 | 2.2 |
| CNhs12055 | Fibroblast - Dermal, donor5 | 2.2 |
| CNhs14538 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1 | 2.1 |
| CNhs13467 | CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1 | 2.1 |
| CNhs12082 | Fibroblast - Lymphatic, donor2 | 2.1 |
| CNhs12794 | K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3 | 2.1 |
| CNhs13465 | CD14+ monocytes - treated with BCG, donor1 | 2.1 |
| CNhs12044 | Smooth Muscle Cells - Carotid, donor3 | 2.1 |
| CNhs12193 | non-small cell lung cancer cell line:NCI-H1385 | 2.1 |
| CNhs11862 | bronchial squamous cell carcinoma cell line:KNS-62 | 2.0 |
| CNhs12422 | MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1 | 2.0 |
| CNhs12858 | throat, adult | 2.0 |
| CNhs11780 | colon, fetal, donor1 | 2.0 |
| CNhs14527 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2 | 2.0 |
| CNhs11905 | Neutrophils, donor3 | 1.9 |
| CNhs14486 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2 | 1.9 |
| CNhs13640 | Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h) | 1.9 |
| CNhs12690 | K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2 | 1.8 |
| CNhs13835 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 1.8 |
| CNhs12116 | Pericytes, donor3 | 1.8 |